Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
AIB Group's Sloan Ratio for the quarter that ended in Dec. 2025 was -2.23%.
As of Dec. 2025, AIB Group has a Sloan Ratio of -2.23%, indicating the company is in the safe zone and there is no funny business with accruals.
AIB Group (OTCPK:AIBRF) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2025, AIB Group has a Sloan Ratio of -2.23%, indicating the company is in the safe zone and there is no funny business with accruals.
AIB Group Sloan Ratio % Related Terms
AIB Group Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for AIB Group's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Banks - Regional subindustry, AIB Group's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AIB Group Sloan Ratio % vs Banks Industry
For the Banks industry and Financial Services sector, AIB Group's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where AIB Group's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
AIB Group's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
AIB Group's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was 1070.358 (Jun. 2025 ) + 1420.375 (Dec. 2025 ) = $2,491 Mil.
AIB Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was 4921.569 (Jun. 2025 ) + 5077.283 (Dec. 2025 ) = $9,999 Mil.
AIB Group's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025 was -2845.444 (Jun. 2025 ) + -798.595 (Dec. 2025 ) = $-3,644 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIB Group (AIBRF) has a Sloan Ratio % of -2.23% as of Dec. 2025. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on AIB Group and its competitors.
Is AIB Group's Sloan Ratio % too high?
AIB Group's current Sloan Ratio % is -2.23%. Overall, AIB Group has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AIB Group's Sloan Ratio % compare to PNC and USB?
AIB Group's Sloan Ratio % of -2.23% can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Banks company?
A good Sloan Ratio % depends on the Banks industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on AIB Group and its competitors. AIB Group's current Sloan Ratio % is -2.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AIB Group stock overvalued right now?
Based on GuruFocus' analysis, AIB Group (AIBRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $7.12, compared to a current price of $11.37 — trading 59.7% above its estimated fair value. The current Sloan Ratio % is -2.23%. AIB Group's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For AIB Group (AIBRF), the current Sloan Ratio % is -2.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AIB Group (AIBRF) Overvalued in 2026?
Based on GuruFocus' analysis, AIB Group stock appears to be overvalued.
The current stock price of $11.37 is trading 59.7% above its estimated GF Value™ of $7.12.
GuruFocus considers AIB Group to be Significantly Overvalued.
Key valuation signals for AIBRF:
Sloan Ratio %: -2.23%
GF Value™: $7.12 vs. price of $11.37 (59.7% above fair value)
No single metric tells the full story. See the AIBRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AIB Group PLC is a banking services company. The company's operating segments are Retail Banking, Capital Markets, AIB UK, Climate & Infrastructure Capital (C&IC), and Group. It generates maximum revenue from the Retail Banking segment. The Retail Banking segment provides products and services through branch, digital, and phone banking channels. It focuses on delivering a seamless and transparent customer experience across all channels, while supporting the development of sustainable businesses within local communities. Geographically, it derives a majority of revenue from Ireland and also has a presence in the United Kingdom and the Rest of the World.
67GF Score
Get the complete analysis for AIBRF
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIBRF has been successfully added to your 
